Revvity | PKI - 流动资产



金融业
股票价格
USD 158.77
资产
USD 12.05B
现金及等价物
USD 1.02B
销售成本
USD 312.82M
流动资产
USD 2.3B
流动负债
USD 1.28B
债务
USD 3.35B
股息收益率
0.25
EBIT
USD 126.14M
EBITDA
USD 228.18M
员工
11K
EPS每股收益
USD 1.41
股本和储备
USD 7.18B
销售毛利
USD 416.87M
债务利息支出
USD 22.99M
利息收入
USD 6.3M
贷款资金
USD 2.63B
市值
USD 19.49B
净收入
USD 51.82M
营业费用
USD 603.55M
营业利润
USD 126.14M
普通股股本
USD 111.63M
PE价格收益
36.47
税前利润
USD 187.24M
销售收入
USD 729.68M
销售和管理费用
USD 278.58M
股票
USD 378.5M
贸易债权人
USD 165.74M
应收帐款人
USD 709.18M


流动资产 更改 日
Agilent USD 4.69B 70M 2026-06
Align Technology USD 2.66B 7.62M 2026-06
Bio Techne USD 744.4M 56.35M 2026-06
Bio-Rad Laboratories USD 3.02B 78.4M 2026-06
Bruker USD 2.22B 121.4M 2026-06
Celltrion KRW 493.66B 12.09B 2026-06
Charles River Laboratories USD 1.53B 40.3M 2026-06
Cspc Pharmaceutical CNY 22.25B 359.48M 2025-12
Danaher USD 14.79B 1.41B 2026-09
Dentsply International USD 1.93B 83M 2026-06
Deva Holding AS TRY 9.13B 1.61B 2023-09
Dianthus Therapeutics USD 897.54M 222.37M 2026-06
Divis Laboratories Ltd INR 110.96B 12.53B 2026-03
Edwards Lifesciences USD 6.82B 590.2M 2026-06
Illumina USD 2.83B 96M 2026-06
Intuitive Surgical USD 10.65B 1.68B 2026-09
IQVIA Holdings USD 6.23B 6M 2026-06
Kangmei Pharma CNY 6.66B 143.43M 2026-06
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Laboratorios Farma EUR 509.33M 128.63M 2023-12
Laboratory Of America USD 3.81B 743.9M 2026-06
Malin Corporation EUR 62.6M 26.7M 2024-12
Medical Developments International AUD 33.75M 1.79M 2025-12
Mesa Laboratories USD 105.63M 8.2M 2025-12
Mettler Toledo International USD 1.35B 15.48M 2026-06
Myriad Genetics USD 289M 23.8M 2026-06
Neuren Pharmaceuticals AUD 332.23M 11.98M 2025-12
OraSure Technologies USD 222.94M 17.84M 2026-06
Organigram Holdings CAD 250.09M 6.46M 2026-03
Ovoca Bio EUR 2.07M 510K 2025-12
Pacific Biosciences Of California USD 338.64M 30.88M 2026-06
Pharma Mar EUR 280.95M 7.5M 2026-06
Qiagen NV USD 1.66B 116.37M 2026-06
Quest Diagnostics USD 3.12B 273M 2026-09
Quidel USD 1.38B 400K 2026-06
Repligen USD 1.2B 39.19M 2026-06
Revvity USD 2.3B 169.4M 2026-06
Sartorius EUR 1.65B 8.4M 2026-09
Sino Biopharmaceutical CNY 33.82B 9.13B 2025-06
Thermo Fisher Scientific USD 25.62B 2.25B 2026-09
Tilray USD 729.32M 28.18M 2025-09
Waters USD 3.9B 186M 2026-06
Zealand Pharma A/S 15.02B 652.12M 2026-03
Zz Pientze Pharmaceu CNY 11.16B 270.46M 2026-06